A study on the prognostic assessment of triple-negative breast cancer using habitat analysis of preoperative DCE-MRI subtraction maps - Summary - MDSpire

A study on the prognostic assessment of triple-negative breast cancer using habitat analysis of preoperative DCE-MRI subtraction maps

  • By

  • Yiming Yao

  • Junfeng Kong

  • Shanshan Jiang

  • Yuan Sun

  • Wanqiu Zhang

  • Jinding Wei

  • Sen Xing

  • Fangsheng Mou

  • Xinghua Liu

  • Wenbing Zeng

  • July 3, 2026

  • 0 min

Share

Objective:

Assessment of disease-free survival (DFS) in triple-negative breast cancer (TNBC) using habitat analysis of preoperative DCE-MRI subtraction maps.

Approach:
  • Study Design: Retrospective collection of consecutive patients with pathologically confirmed TNBC from January 2019 to January 2025.
  • Data Collection: DCE subtraction maps were used to obtain wash-in and washout ratio maps for habitat analysis.
  • Statistical Analysis: Kaplan-Meier survival analysis and multivariable Cox regression analyses were performed to identify independent risk factors for TNBC recurrence.
Key Findings:
  • 145 patients were enrolled, with 29 experiencing recurrence.
  • Habitat intratumoral heterogeneity (ITH) was significantly higher in the high-risk recurrence group (0.59 ± 0.14) compared to the low-risk group (0.42 ± 0.22, P < 0.001).
  • The AUC for habitat ITH in diagnosing TNBC recurrence was 0.71 (95% CI: 0.616-0.805, P < 0.05).
  • Habitat ITH was identified as an independent predictor of poorer DFS (HR 1.465, 95% CI: 1.086-2.073, P = 0.013).
Interpretation:

Habitat analysis of preoperative DCE-MRI subtraction maps contributes to the prognostic assessment of TNBC.

Limitations:
  • The study is retrospective and may have inherent biases that could affect the generalizability of the findings.
  • The biological interpretation of subregions segmented via unsupervised clustering may be ambiguous, complicating the understanding of tumor heterogeneity.
Conclusion:

Habitat analysis using DCE-MRI subtraction maps provides a novel imaging basis for assessing tumor heterogeneity and prognostic evaluation in TNBC.

Original Source(s)

Related Content